Mechanism of metronidazole-resistance by isolates of nitroreductase- producing Enterococcus gallinarum and Enterococcus casseliflavus from the human intestinal tract

FEMS Microbiology Letters

Volumn 225, Issue 2, 2003, Pages 195-200

  Rafii, Fatemeh ^a   Wynne, Rebecca ^a   Heinze, Thomas M ^a   Paine, Donald D ^a  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

Enterococcus; Intestinal bacteria; Metronidazole; Nitroreductase

Indexed keywords

ANTIBIOTIC AGENT; METRONIDAZOLE; NITROFURAL; NITROFURANTOIN; NITROREDUCTASE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GROWTH; BACTERIUM CULTURE; BACTERIUM ISOLATE; CLOSTRIDIUM PERFRINGENS; CONTROLLED STUDY; ENTEROCOCCUS CASSELIFLAVUS; ENTEROCOCCUS GALLINARUM; ENZYME RELEASE; FECES ANALYSIS; HUMAN; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; RECURRENT DISEASE; ULCERATIVE COLITIS; ULTRAVIOLET SPECTROSCOPY; BIOSYNTHESIS; DRUG EFFECT; ELECTROSPRAY MASS SPECTROMETRY; ENTEROCOCCUS; FECES; GROWTH, DEVELOPMENT AND AGING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTESTINE; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY;

CLOSTRIDIUM; CLOSTRIDIUM PERFRINGENS; ENTEROCOCCUS; ENTEROCOCCUS CASSELIFLAVUS; ENTEROCOCCUS GALLINARUM;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CLOSTRIDIUM PERFRINGENS; DRUG RESISTANCE, BACTERIAL; ENTEROCOCCUS; FECES; HUMANS; INTESTINES; METRONIDAZOLE; NITROREDUCTASES; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 1642290188     PISSN: 03781097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1097(03)00513-5     Document Type: Article

References (19)

1. Edwards D.I. Nitroimidazole drugs, action and resistance mechanisms. I. Mechanisms of action. J. Antimicrob. Chemother. 31:1993;201-210.
2. Freeman C.D., Klutman N.E., Lamp K.C. Metronidazole. A therapeutic review and update. Drugs. 54:1997;679-708.
3. Hoffman P.S., Goodwin A., Johnson J., Magee K., Veldhuyzen van Zanten S.J.O. Metabolic activities of metronidazole sensitive and resistant strains of Helicobacter pylori: Repression of pyruvate oxidoreductase and expression of isocitrate lysate activity correlated with resistance. J. Bacteriol. 178:1996;4822-4829.
4. Byers K.E., Anglim A.M., Anneski C.J., Germanson T.P., Gold H.S., Durbin L.J., Simonton B.R., Farr B.R. A hospital epidemic of vancomycin-resistant Enterococcus: Risk factors and control. Infect. Contr. Hosp. Epidemiol. 22:2001;140-147.
5. Edmond M.B., Ober J.F., Weinbaum D.L., Pfaller M.A., Hwang T., Sanford M.D., Wenzel R.P. Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection. Clin. Infect. Dis. 20:1995;1126-1133.
6. Linden P.K., Miller C.B. Vancomycin-resistant enterococci: the clinical effect of a common nosocomial pathogen. Diagn. Microbiol. Infect. Dis. 33:1999;113-120.
7. Carmeli Y., Eliopoulos G.M., Samore M.H. Antecedent treatment with different antibiotic agents as a risk factor for vancomycin-resistant Enterococcus. Emerg. Infect. Dis. 8:2002;802-807.
8. Miyazaki S., Fujikawa T., Kobayashi I., Matsumoto T., Tateda K., Yamaguchi K. Development of systemic bacteraemia after oral inoculation of vancomycin-resistant enterococci in mice. J. Med. Microbiol. 50:2001;695-701.
9. Donskey C.J., Hanrahan J.A., Hutton R.A., Rice L.B. Effect of parenteral antibiotic administration on persistence of vancomycin-resistant Enterococcus faecium in the mouse gastrointestinal tract. J. Infect. Dis. 180:1999;384-390.
10. Knox R.J., Knight R.C., Edwards D.I. Studies on the action of nitroimidazole drugs, the products of nitroimidazole reduction. Biochem. Pharmacol. 32:1983;2149-2156.
11. Carlier J.P., Sellier N., Rager M.N., Reysset G. Metabolism of 5-nitroimidazole in susceptible and resistant isogenic strains of Bacteroides fragilis. Antimicrob. Agents Chemother. 41:1997;1495-1499.
12. Chrystal E.J.T., Koch R.L., Goldman P. Metabolites from the reduction of metronidazole by xanthine oxidase. Mol. Pharmacol. 18:1980;105-111.
13. Chrystal E.J., Koch R.L., McLafferty M.A., Goldman P. Relationship between metronidazole metabolism and bactericidal activity. Antimicrob. Agents Chemother. 18:1980;566-573.
14. Rafii F., Franklin W., Heflich R.H., Cerniglia C.E. Reduction of nitroaromatic compounds by anaerobic bacteria isolated from the human gastrointestinal tract. Appl. Environ. Microbiol. 57:1991;962-968.
15. Rafii F., Hansen E.B. Isolation of nitrofurantoin-resistant mutant nitroreductase-producing Clostridium sp. strains from the human intestinal tract. Antimicrob. Agents Chemother. 42:1998;1121-1126.
16. Zenno S., Saigo K. Identification of the genes encoding NAD(P)H-flavin oxidoreductases that are similar in sequence to Escherichia coli Fre in four species of luminous bacteria: Photorhabdus luminescens, Vibrio fischeri, Vibrio harveyi and Vibrio orientalis. J. Bacteriol. 176:1994;3544-3551.
17. Rafii F., Hehman G., Lunsford P. Purification and characterization of an enzyme from Mycobacterium sp. Pyr-1, with nitroreductase activity and an N-terminal sequence similar to lipoamide dehydrogenase. Arch. Microbiol. 176:2001;381-385.
18. Koch R.L., Chrystal E.J., Beaulieu B.B., Goldman P. Acetamide-a metabolite of metronidazole formed by the intestinal flora. Biochem. Pharmacol. 28:1979;3611-3615.
19. Koch R.L., Goldman P. The anaerobic metabolism of metronidazole forms N-(2-hydroxyethyl)-oxamic acid. J. Pharmacol. Exp. Ther. 208:1978;406-410.